Antifungal Drug Market Size, Share, Growth, Report 2028
Antifungal Drug Market - By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Aspergillosis, Dermatophytosis, and Candidiasis), By Dosage Form (Powder, Ointments, and Tablets), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies & Drug Stores), and By Region: Global Industry Perspective, Comprehensive Analysis, And Forecast, 2022 - 2028
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 15.1 Billion | USD 20.23 Billion | 3.7% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Antifungal Drug Market, 2016-2026 (USD Billion)
- 2.2. Antifungal Drug Market: Snapshot
- Chapter 3. Antifungal Drug Market - Industry Analysis
- 3.1. Antifungal Drug Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Rapid Spread Of Fungal Infection
- 3.2.2. Pandemicity Of Fungal Infection
- 3.3. Restraints
- 3.3.1. High Penetration Of Conventional Drugs
- 3.4. Opportunity
- 3.4.1. Covering Untapped Market
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Drug Type
- 3.6.2. Market attractiveness analysis By Dosage Form
- 3.6.3. Market attractiveness analysis By Therapeutic Indication
- 3.6.4. Market attractiveness analysis by Region
- Chapter 4. Antifungal Drug Market- Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Antifungal Drug Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Drug Type launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Antifungal Drug Market -Drug Type Analysis
- 5.1. Global Antifungal Drug Market overview: By Drug Type type
- 5.1.1. Global Antifungal Drug Market share, By Drug Type,2019 and 2026
- 5.2. Echinocandins
- 5.2.1. Global Antifungal Drug Market by Echinocandins, 2016-2026 (USD Billion)
- 5.3. Azoles
- 5.3.1. Global Antifungal Drug Market by Azoles, 2016-2026 (USD Billion)
- 5.4. Ployenes
- 5.4.1. Global Antifungal Drug Market by Ployenes, 2016-2026 (USD Billion)
- 5.5. Allylamines
- 5.5.1. Global Antifungal Drug Market by Allylamines, 2016-2026 (USD Billion)
- 5.6. Others
- 5.6.1. Global Antifungal Drug Market by others, 2016-2026 (USD Billion)
- 5.1. Global Antifungal Drug Market overview: By Drug Type type
- Chapter 6. Global Antifungal Drug Market -Dosage Form Analysis
- 6.1. Global Antifungal Drug Market overview: By Dosage Form
- 6.1.1. Global Antifungal Drug Market share, By Dosage Form, 2019 and 2026
- 6.2. Powders
- 6.2.1. Global Antifungal Drug Market By Powders, 2016-2026 (USD Billion)
- 6.3. Ointments
- 6.3.1. Global Antifungal Drug Market By Ointments, 2016-2026 (USD Billion)
- 6.4. Drugs
- 6.4.1. Global Antifungal Drug Market By Drugs, 2016-2026 (USD Billion)
- 6.5. Pastes
- 6.5.1. Global Antifungal Drug Market By Pastes, 2016-2026 (USD Billion)
- 6.1. Global Antifungal Drug Market overview: By Dosage Form
- Chapter 7. Global Antifungal Drug Market -Therapeutic Indication Analysis
- 7.1. Global Antifungal Drug Market overview: By Therapeutic Indication
- 7.1.1. Global Antifungal Drug Market share, By Therapeutic Indication, 2019 and 2026
- 7.2. Aspergillosis
- 7.2.1. Global Antifungal Drug Market by Aspergillosis, 2016-2026 (USD Billion)
- 7.3. Dermatophytosis
- 7.3.1. Global Antifungal Drug Market by Dermatophytosis, 2016-2026 (USD Billion)
- 7.4. Candidiasis
- 7.4.1. Global Antifungal Drug Market by Candidiasis, 2016-2026 (USD Billion)
- 7.5. Others
- 7.5.1. Global Antifungal Drug Market by others, 2016-2026 (USD Billion)
- 7.1. Global Antifungal Drug Market overview: By Therapeutic Indication
- Chapter 8. Global Antifungal Drug Market - Regional Analysis
- 8.1. Global Antifungal Drug Market overview: by Region
- 8.1.1. Global Antifungal Drug Marketshare, by Region, 2019 and 2026
- 8.2. North America
- 8.2.1. North America Antifungal Drug Market, 2016-2026 (USD Billion)
- 8.2.2. North America Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.2.3. North America Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.2.4. North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S.Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.2.5.2. The U.S.Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.2.5.3. The U.S.Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.2.6.2. Rest of North America Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.2.6.3. Rest of North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Antifungal Drug Market, 2016-2026 (USD Billion)
- 8.3.2. Europe Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.3.3. Europe Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.3.4. Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.3.5. UK
- 8.3.5.1. U.K.Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.3.5.2. U.K.Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.3.5.3. U.K. Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.3.6. France
- 8.3.6.1. France Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.3.6.2. France Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.3.6.3. France Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.3.7. Germany
- 8.3.7.1. Germany Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.3.7.2. Germany Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.3.7.3. Germany Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of EuropeAntifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.3.8.2. Rest of EuropeAntifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.3.8.3. Rest of Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Antifungal Drug Market, 2016-2026 (USD Billion)
- 8.4.2. Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.4.3. Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.4.4. Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.4.5.2. China Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.4.5.3. China Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.4.6.2. Japan Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.4.6.3. Japan Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.4.7.2. India Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.4.7.3. India Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Antifungal Drug Market, 2016-2026 (USD Billion)
- 8.5.2. Latin America Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.5.3. Latin America Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.5.4. Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.5.5.2. Brazil Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.5.5.3. Brazil Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.5.6. Rest of LatinAmerica
- 8.5.6.1. Rest of LatinAmerica Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.5.6.2. Rest of LatinAmerica Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.5.6.3. Rest of Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Antifungal Drug Market, 2016-2026 (USD Billion)
- 8.6.2. The Middle East and Africa Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
- 8.6.3. The Middle East and Africa Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
- 8.6.4. The Middle East and Africa Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
- Chapter 9. Company Profiles
- 9.1. Asperqillus
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Drug Type Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Alternaria
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Drug Type Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Abbott Laboratories
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Drug Type Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Pfizer
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Drug Type Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Glaxosmithkline
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Drug Type Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Development
- 9.6. Bayer Healthcare
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Drug Type Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Development
- 9.7. Novartis
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Drug Type Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Development
- 9.8. Sanofi-Aventis
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Drug Type Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Development
- 9.9. Merck & Co.
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Drug Type Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Development
- 9.10. Kramer Laboratories
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Drug Type Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Development
- 9.1. Asperqillus
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Antifungal Drug Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Antifungal Drug Market attractiveness, By Drug Type type
6. Global Antifungal Drug Market attractiveness, By Dosage Form
7. Global Antifungal Drug Market attractiveness, By Therapeutic Indication
8. Global Antifungal Drug Marketmarket share, By Drug Type, 2019 and 2026
9. Global Antifungal Drug Market by Echinocandins, 2016–2026 (USD Billion)
10. Global Antifungal Drug Market by Azoles,2016–2026 (USD Billion)
11. Global Antifungal Drug Market by Ployenes,2016–2026 (USD Billion)
12. Global Antifungal Drug Market by Allylamines,2016–2026 (USD Billion)
13. Global Antifungal Drug Market by Others,2016–2026 (USD Billion)
14. Global Antifungal Drug Market share, By Dosage Form, 2019 and 2026
15. Global Antifungal Drug Market By Powders, 2016–2026 (USD Billion)
16. Global Antifungal Drug Market By Ointments, 2016–2026 (USD Billion)
17. Global Antifungal Drug Market By Drugs, 2016–2026 (USD Billion)
18. Global Antifungal Drug Market By Pastes, 2016–2026 (USD Billion)
19. Global Antifungal Drug Market share, By Therapeutic Indication, 2019 and 2026
20. Global Antifungal Drug Market by Aspergillosis, 2016–2026 (USD Billion)
21. Global Antifungal Drug Market by Dermatophytosis, 2016–2026 (USD Billion)
22. Global Antifungal Drug Market by Candidiasis, 2016–2026 (USD Billion)
23. Global Antifungal Drug Market by Others, 2016–2026 (USD Billion)
24. Global Antifungal Drug Market share, by Region, 2019and 2026
25. North America Antifungal Drug Market, 2016–2026 (USD Billion)
26. Europe Antifungal Drug Market, 2016–2026 (USD Billion)
27. Asia Pacific Antifungal Drug Market, 2016–2026 (USD Billion)
28. Latin America Antifungal Drug Market, 2016–2026 (USD Billion)
29. The Middle East and Africa Antifungal Drug Market, 2016–2026 (USD Billion)
Table Of Tables
List of Tables
1. Global Antifungal Drug Market: snapshot
2. Drivers of theAntifungal Drug Market: impact analysis
3. Restraints of theAntifungal Drug Market: impact analysis
4. North America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
5. North America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
6. North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
7. The U.S. Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
8. The U.S. Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
9. The U.S. Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
10. Rest of North America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
11. Rest of North America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
12. Rest of North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
13. Europe Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
14. Europe Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
15. Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
16. U.K.Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
17. U.K.Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
18. U.K. Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
19. France Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
20. France Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
21. France Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
22. Germany Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
23. Germany Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
24. Germany Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
25. Rest of EuropeAntifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
26. Rest of EuropeAntifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
27. Rest of Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
28. Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
29. Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
30. Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
31. China Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
32. China Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
33. China Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
34. Japan Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
35. Japan Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
36. Japan Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
37. India Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
38. India Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
39. India Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
40. Rest of Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
41. Rest of Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
42. Rest of Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
43. Latin America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
44. Latin America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
45. Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
46. Brazil Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
47. Brazil Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
48. Brazil Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
49. Rest of Latin America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
50. Rest of Latin America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
51. Rest of Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
52. The Middle East and Africa Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
53. The Middle East and Africa Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
54. The Middle East and Africa Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
Methodology
FrequentlyAsked Questions
Occurrence of fungal infections in immune-compromised patients such as AIDS, cancer patients, and individuals affected due to autoimmune disorders will offer new growth avenues for antifungal drug industry.
According to a study, the global antifungal drug market size was worth around USD 15.1 billion in 2021 and is expected to reach USD 20.23 billion by 2028 at a CAGR of 3.7% during the forecast period.
North America is expected to dominate the antifungal drug market over the forecast period.
Leading players in the global antifungal drug market include Aspergillus, Abbott Laboratories, Alternaria, Enzon Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., GlaxoSmithKline plc, Bayer Healthcare, Novartis AG, Sanofi S.A., Kramer Laboratories, and Gilead Sciences, Inc., among others.
The antifungal drug market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed